Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 9:15:1509109.
doi: 10.3389/fpsyt.2024.1509109. eCollection 2024.

Phytochemicals in the treatment of patients with depression: a systemic review

Affiliations

Phytochemicals in the treatment of patients with depression: a systemic review

Natalia Picheta et al. Front Psychiatry. .

Abstract

Background: Depression is a complex mental disease whose incidence increases every year; 300 million people worldwide currently suffer from it. Women are more likely to suffer from depression, twice the rate as men. It is one of the few illnesses that can lead to suicide, which makes it very dangerous - currently, 700,000 people die from suicide and it is the 4th most common cause of death in people aged 15-29. The treatment strategies for depression is a big challenge for physicians, pharmacists, scientists and classic remedies cause many side effects. Therefore, natural phytotherapy with herbs can prove to be a good solution. Phytotherapy is a popular treatment method used for centuries in Chinese medicine or Ayurveda.

Materials and methods: The study conducted a comprehensive database search PubMed, ClinicalKey and MedNar covered the years 2015 - 2024 to provide the most up-to-date data. 13 randomized controlled trials and 1 meta - analysis were included in the systematic review.

Results: Many plants show anti-inflammatory, antioxidant and cognitive enhancing effects, which are particularly important in depression. In the treatment of depression, plants such as Crocus sativus L. stigma, Lavandula angustifolia, Hypericum perforatum L. and Curcuma longa L. have proven to be effective. They show good effectiveness in human studies and alleviate the symptoms of depression. Herbal products can support classical pharmacotherapy, but this requires further research. Non-commercial clinical trials in the future should provide answers to research questions: at what stage of treatment of patients with MDD will the use of phytochemicals be most appropriate in terms of therapy efficacy and safety for the patient.

Conclusions: Crocus sativus L. stigma, Lavandula angustifolia, Hypericum perforatum L. and Curcuma longa L. in modern medicine can help improve the well-being of patients with depression. The use of herbs as an intervention was associated with a decrease in the concentration of proinflammatory cytokines and an overall improvement in the mood of patients. Further research should be undertaken into combining both therapies in order to improve patients' quality of life and reduce treatment costs.

Keywords: St. John’s wort; depression; lavender; phytochemicals; saffron; turmeric.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Massive depression disorders treatment algorithm based on National Institute for Health and Care Excellence (NICE) guidelines (9).
Figure 2
Figure 2
Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) flow diagram of study identification, inclusion, and exclusion.
Figure 3
Figure 3
Summary of all the medicinal effects of saffron, lavender, turmeric and H. perforatum L. (20, 24, 26, 35).
Figure 4
Figure 4
Other potential effects of curcumin in combating depression – acts as an antioxidant, has a positive effect on neuroplasticity in the brain, protects mitochondria and therefore reduces oxidative stress, regulates the endocannabinoid system – influences the modulation of inflammatory reactions and anxiety, and regulates serotonin, dopamine and glutamate (49, 61, 69).

References

    1. Serretti A. Advances in the treatment of depression. Int Clin Psychopharmacol. (2022) 37:183–4. doi: 10.1097/YIC.0000000000000424 - DOI - PubMed
    1. World Health Organization . Depressive disorder (depression) (2023). Available online at: https://www.who.int/news-room/fact-sheets/detail/depression (Accessed March 31, 2023).
    1. Penner-Goeke S, Binder EB. Epigenetics and depression. Dialogues Clin Neurosci. (2019) 21:397–405. doi: 10.31887/DCNS.2019.21.4/ebinder - DOI - PMC - PubMed
    1. Dobrek L, Głowacka K. Depression and its phytopharmacotherapy-A narrative review. Int J Mol Sci. (2023) 24:4772. doi: 10.3390/ijms24054772 - DOI - PMC - PubMed
    1. Chan VKY, Leung MYM, Chan SSM, Yang D, Knapp M, Luo H, et al. . Projecting the 10-year costs of care and mortality burden of depression until 2032: a Markov modelling study developed from real-world data. Lancet Regional Health Western Pac. (2024) 45:101026. doi: 10.1016/j.lanwpc.2024.101026 - DOI - PMC - PubMed

Publication types

LinkOut - more resources